PCVX ▼ -0.9% - Vaxcyte, Inc. $PCVX Vaxcyte: Prices $500M Equity Offering at $64 per Share and $500M Convertible Notes Offering ? • Equity offering includes 7.41M shares plus pre-funded warrants for 400,000 shares; underwriters have an option for up to 1.17M additional shares. • Convertible notes carry 1.50% interest, mature in 2032 and initially convert at ~$89.60 per share, a 40% premium to the equity offering price. • Offerings are expected to close Oct. 9, with proceeds supporting VAX-31 development, manufacturing expansion, inventory and potential U.S. launch preparations. 07-OCT-2026 05:21 AM ET